Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546

Related Posts

Artificial Intelligence and Patient-centric Approaches to Advance Pharmaceutical Innovation

August, 2019

Kenneth I. Kaitin, PhD, Tufts Center for the Study of Drug Development

Clin Ther. 2019 Aug; 41(8):1406-1407. doi: 10.1016/j.clinthera.2019.06.014. Epub 2019 Jul 25.
PMID: 31353132 | DOI: 10.1016/j.clinthera.2019.06.014

 

Abstract

Since the start of this century, stunning advances in our understanding of the pathophysiology and genetic determinants of a host of diseases that currently lack adequate and effective treatments have opened the door to new avenues of biomedical innovation. In many cases, however, these scientific advances have not translated into the development of new and better medicines, especially for a number of diseases that take an exacting toll in morbidity and mortality, including heart disease, stroke, diabetes, obesity, and dementia.

 

Source: https://www.clinicaltherapeutics.com/article/S0149-2918(19)30341-8/fulltext